Rhoen Klinikum AG (WBO:RHK) FFO


WBO:RHK Rhoen Klinikum AG WBO:RHK
74 GF Score
Price €14.10
GF Value €13.49
! 3 Warning Signs
View Full Analysis

What is Rhoen Klinikum AG FFO?

FFO (Funds from operations) only applies to REITs.

WBO:RHK
74GF Score
Rhoen Klinikum AG WBO:RHK
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Rhoen Klinikum AG (WBO:RHK) Overvalued in 2026?

Based on GuruFocus' analysis, Rhoen Klinikum AG stock appears to be overvalued. The current stock price of €14.10 is trading 4.5% above its estimated GF Value™ of €13.49.

Key valuation signals for WBO:RHK:

  • FFO:
  • GF Value™: €13.49 vs. price of €14.10 (4.5% above fair value)
  • GF Score™: 74/100 with 3 warning signs

No single metric tells the full story. See the WBO:RHK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Rhoen Klinikum AG Business Description

Other Exchanges 0NQH:UKRHK:Germany
Address Salzburger Leite 1, Bad Neustadt a. d. Saale, DEU, 97616
Rhoen Klinikum AG provides medical care and healthcare services. The firm operates in three business areas: acute hospitals, medical care centers, and rehabilitation hospitals. The acute hospitals business contributes to the vast majority of the firm's overall revenue. The majority of patients at the firm's acute hospitals and medical care centers are treated on inpatient, semi-inpatient and outpatient healthcare basis. The company generates the entire revenue in Germany, with the Bavaria and Hesse regions contributing the majority proportions of revenue.
74GF Score

Get the complete analysis for WBO:RHK

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€14.10
Price
€13.49
GF Value